SEARCH

SEARCH BY CITATION

References

  • 1
    Farmer DG, Amersi F, Kupiec-Weglinski JW, Busuttil RW. Current status of ischemia and reperfusion injury in the liver. Transplant Rev 2000; 14: 106126.
  • 2
    Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts: overview and synthesis of current studies. Transplantation 1992; 53: 957978.
  • 3
    Lermasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Ann Rev Pharmacol Toxicol 1997; 37: 327338.
  • 4
    Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionary conserved mediators of immune response. Ann Rev Immunol 1998; 16: 225260.
  • 5
    Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA, Jr. Role of tumor necrosis factor-α in the pathophysiologic alternations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 19361943.
  • 6
    Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 1998; 27: 11721177.
  • 7
    Colletti LM, Cortis A, Lukacs N, Kunkel SL, Green M, Strieter RM. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998; 10: 182191.
  • 8
    Kohli V, Selzner M, Madden JF, Bentley RC, Clavien P. A. Endothelial cells and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999; 67: 10991105.
  • 9
    Gottlieb RA, Burleson KO, Kloner PA, Babior BM, Eugler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 16211628.
  • 10
    Krams SM, Egawa H, Quinn MB et al. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995; 59: 621625.
  • 11
    Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of prevention injury in rat liver transplantation. Hepatology 1998; 27: 16521660.
  • 12
    Natori S, Selzner M, Valentino K et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1998; 68: 8996.
  • 13
    Sasaki H, Matsuno T, Ishikawa T, Sadamori H, Yagi T, Tanaka N. Activation of apoptosis during early phase of reperfusion after liver transplantation. Transplant Proc 1997; 29: 406407.
  • 14
    Gao W, Washington MC, Bentley RC, Clavein PA. Antiangiogenic agents protect liver sinusoidal lining cells from cold preservation injury in rat liver transplantation. Gastroenterology 1997; 113: 16921700.
  • 15
    Minty A, Chalon P, Derocq JM et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248250.
  • 16
    Berkman N, John M, Roesems G, Jose P, Barnes PJ, Chung KF. Interleukin 13 inhibits macrophage inflammatory protein-1α production from human alveolar macrophages and monocytes. Am J Respir Cell Mol Biol 1996; 15: 382389.
  • 17
    Muchamuel T, Menon S, Pisacane P, Howard MC, Cockayne DA. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia. correlation with down-modulation of TNF-α, IFN-γ, and IL-12 production. J Immunol 1997; 158: 28982903.
  • 18
    Mulligan MS, Warner RL, Foreback JL, Shanley TP, Ward PA. Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury. J Immunol 1997; 159: 34833489.
  • 19
    Woods JM, Amin A, Katschke KJ et al. Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum Gene Ther 2002; 13: 381393.
  • 20
    Manna SK, Aggarwal BB. IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1, and apoptosis. J Immunol 1998; 161: 28632872.
  • 21
    Relic B, Guicheux J, Mezin F et al. IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. J Immunol 2001; 166: 27752782.
  • 22
    Evans PC, Kilshaw PJ. Interleukin-13 protects endothelial cells from apoptosis and activation: association with the protective genes A20 and A1. Transplantation 2000; 70: 928934.
  • 23
    Ke B, Shen XD, Lassman CR et al. IL-13 gene transfer protects rat livers from antigen-independent injury induced by ischemia and reperfusion. Transplantation 2003; 75: 11181123.
  • 24
    Ke B, Shen XD, Gao F et al. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum Gene Ther 2002; 13: 18451857.
  • 25
    Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation 1993; 55: 12651272.
  • 26
    Ke B, Ritter T, Kato H et al. Regulatory cells potentiate the efficacy of IL-4 gene therapy by upregulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients. J Immunol 2000; 164: 57395745.
  • 27
    Yoshidome H, Kato A, Miyazaki M, Edwards MJ, Lentsch AB. IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion. Am J Pathol 1999; 155: 10591064.
  • 28
    Amersi F, Buelow R, Kato H et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999; 104: 16311639.
  • 29
    Amersi F, Farmer DG, Shaw GD et al. P-selectin glycoprotein ligand-1 (rPSGL-Ig) mediated blockade of CD62 selectin molecules protects steatotic liver grafts from ischemia/reperfusion injury. Am J Transplant 2002; 2: 600608.
  • 30
    Sawitzki B, Amersi F, Ritter T et al. Upregulation of Bag-1 by ex-vivo gene transfer protects rat livers from ischemia/reperfusion injury. Hum Gene Ther 2002; 13: 14951504.
  • 31
    Lomo J, Blomhoff HK, Jacobsen SE, Krajewski S, Reed JC, Smeland EB. Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-Xl and Mcl-1. Blood 1997; 89: 44154424.
  • 32
    Honey K, Cobbold SP, Waldmann H. Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas–FasL interactions. Transplantation 2000; 69: 16831689.
  • 33
    Wagener ME, Konieczny BT, Dai Z, Ring GH, Lakkis FG. Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance. Transplantation 2000; 69: 24282432.
  • 34
    Shen XD, Ke B, Zhai Y et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of STAT4 disruption-mediated cytoprotection. Hepatology 2003; 37: 296303.
  • 35
    Kato H, Amersi F, Buelow R et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 2001; 1: 121128.
  • 36
    Lee T-S, Chau L-Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002; 8: 240246.
  • 37
    Katori M, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase 1 system in organ transplantation. Transplantation 2002; 74: 905912.